Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4743 results found.

Example of search result explained

Riva-Pyrantel Pamoate

Covered
  • Active ingredient(s):
    pyrantel pamoate
  • Manufactured by:
    Laboratoire Riva Inc. (Riva)
  • Strength and dosage form:
    Tablet 125 mg DIN : 2535467

Rivastigmine Patch 5

Exceptional medication
  • Active ingredient(s):
    rivastigmine
  • Manufactured by:
    Pharmascience Inc. (Phmscience)
  • Strength and dosage form:
    Patch 4.6 mg/24H DIN : 2479540

Rivastigmine Patch 10

Exceptional medication
  • Active ingredient(s):
    rivastigmine
  • Manufactured by:
    Pharmascience Inc. (Phmscience)
  • Strength and dosage form:
    Patch 9.5 mg/24H DIN : 2479559

Teva-Sitagliptin malate / Metformin

Exceptional medication
  • Active ingredient(s):
    sitagliptin/metformin hydrochloride
  • Manufactured by:
    Teva Canada Ltée (Teva Can)
  • Strength and dosage form:
    • Tablet 50 mg -1000 mg DIN : 2520516
    • Tablet 50 mg -500 mg DIN : 2520494
    • Tablet 50 mg -850 mg DIN : 2520508

Taro-Tofacitinib XR

Exceptional medication
  • Active ingredient(s):
    tofacitinib citrate
  • Manufactured by:
    Taro Pharmaceuticals Inc. (Taro)
  • Strength and dosage form:
    Long-Action Tablet 11 mg DIN : 2553988

Steqeyma

Exceptional medication
  • Active ingredient(s):
    ustekinumab (ulcerative colitis and Crohn's disease)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114386
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114387
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2550261

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis children)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114450
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114448
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114447
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 99114445
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 99114446

pms-Vancomycin

Covered
  • Active ingredient(s):
    vancomycin hydrochloride
  • Manufactured by:
    Pharmascience Inc. (Phmscience)
  • Strength and dosage form:
    • Capsule 125 mg DIN : 2406497
    • Capsule 250 mg DIN : 2406500

Mint-Venlafaxine XR

Covered
  • Active ingredient(s):
    venlafaxine chlorhydrate
  • Manufactured by:
    Mint Pharmaceuticals Inc. (Mint)
  • Strength and dosage form:
    • Long Action Capsule 150 mg DIN : 2522993
    • Long Action Capsule 37.5 mg DIN : 2522977
    • Long Action Capsule 75 mg DIN : 2522985

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2502380
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2502399
Page 470 of 475

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.